Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has approved Rotem hemostasis delta analyzer which provides complete information about patients' coagulation status.
Subscribe to our email newsletter
The delta analyzer facilitates surgeons by providing key information in just 5-10 minutes which enables surgical team to decide whether platelets, plasma, red blood cells or other blood components are in proper balance or need to be augmented by transfusion.
Rotem president Ken West said they can provide the delta analyzer to hospitals, blood banks and research centers thorough training and support from their headquarters in the Research Triangle Park area.